Atlas Trials

Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch

Clinical trial NCT06048536 · COMPLETED

Trial details

NCT number
NCT06048536
Sponsor
Mylan Pharmaceuticals Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Contraception
Start date
2023-12-22
Primary completion
2024-01-18
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.